Pharmaceuticals

Losartan Potassium Active Pharmaceutical Ingredient (API) Market to Reach $2.39 Billion by 2029, Growing at a CAGR of 6.5%

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Expected Total Market Size Of The Losartan Potassium Active Pharmaceutical Ingredient (API) Industry By The Forecast Year 2029?

The losartan potassium active pharmaceutical ingredient (api) market size has shown significant growth in recent years. It is forecast to increase from $1.75 billion in 2024 to $1.85 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 6.0%. The expansion observed in prior periods is attributable to the expanding uptake of antihypertensive drugs, the rising prevalence of lifestyle-related ailments, heightened awareness regarding cardiovascular health, an increase in global healthcare spending, and the growing demand for economical generic medicines.

The losartan potassium active pharmaceutical ingredient (api) market size is anticipated to experience robust expansion over the coming years, with projections indicating it will reach $2.39 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.5%. This growth during the forecast period is primarily driven by an enlarging patient base suffering from chronic conditions, an increasing emphasis on proactive cardiovascular health, wider accessibility of healthcare services in developing markets, breakthroughs in drug formulation techniques, and rising government programs promoting generic medications. Significant trends expected in this period encompass improvements in manufacturing processes, sophisticated drug delivery systems, the creation of pediatric-suitable formulations, innovations in packaging to enhance product longevity, and the introduction of combination therapies incorporating losartan.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24285&type=smp

Which Major Market Drivers Are Shaping The Future Of The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?

The increasing occurrence of high blood pressure is anticipated to drive the expansion of the losartan potassium active pharmaceutical ingredient (API) market in the future. This condition, characterized by consistently elevated blood pressure, significantly increases the risk of cardiovascular illnesses, strokes, and other serious health issues. An escalating occurrence of hypertension is often associated with diets high in sodium and processed foods, contributing to fluid retention and greater stress on the heart. Losartan potassium assists in managing hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This action aids in relaxing and expanding these vessels, thereby reducing blood pressure and alleviating the heart’s effort. As an illustration, figures from January 2024 released by the American Heart Association, a US-based nonprofit organization, showed 131,454 deaths primarily attributed to high blood pressure in 2022, representing an increase from 124,508 deaths recorded in 2021. Consequently, the expanding prevalence of hypertension is fueling the growth of the losartan potassium active pharmaceutical ingredient (API) market.

What Are The Segment Types Shaping The Losartan Potassium Active Pharmaceutical Ingredient (API) Market?

The losartan potassium active pharmaceutical ingredient (api) market covered in this report is segmented –

1) By Product Type: Tablet, Capsule, Other Product Types

2) By Production Method: Synthetic Route, Biotechnological Process, Continuous Flow Production

3) By Distribution Channel: Online Pharmacies, Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels

4) By Application: Hypertension, Heart Failure, Chronic Kidney Diseases, Other Applications

5) By End-User: Hospitals, Clinics, Home Care Settings, Pharmaceutical Companies

Subsegments:

1) By Tablet: Immediate-Release Tablets, Extended-Release Tablets, Film-Coated Tablets, Orally Disintegrating Tablets

2) By Capsule: Hard Gelatin Capsules, Soft Gelatin Capsules, Modified-Release Capsules

3) By Other Product Types: Injectable Formulations, Bulk Active Pharmaceutical Ingredient (API) Powder, Granules For Suspension, Pre-Formulated Intermediates

Which Ongoing Trends Are Expected To Shape The Losartan Potassium Active Pharmaceutical Ingredient (API) Market Outlook?

Leading companies in the losartan potassium active pharmaceutical ingredient (API) market are concentrating on developing innovative products and securing approvals, such as losartan potassium oral suspension, to enhance patient compliance and expand therapeutic applications. Losartan potassium oral suspension is a liquid form of losartan potassium medication, intended for individuals who struggle with swallowing tablets. For example, in March 2025, Scienture Holdings Inc., a US-based biopharmaceutical company, received Food and Drug Administration (FDA) approval for Arbli. Arbli is a ready-to-use liquid formulation for hypertension, stroke risk reduction in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in type 2 diabetes patients. It provides precise dosing without compounding and is available as a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.

Who Are The Top Performing Companies In The Losartan Potassium Active Pharmaceutical Ingredient (API) Market In Recent Years?

Major companies operating in the losartan potassium active pharmaceutical ingredient (API) market are Teva Pharmaceutical Industries Ltd, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd, Dr. Reddy’s Laboratories, Cadila Pharmaceuticals Ltd, Lupin Ltd, Zydus Lifesciences Ltd, Alkem Laboratories Ltd, IPCA Laboratories Ltd, Alembic Pharmaceuticals Ltd, Granules India Limited, Vasudha Pharma Chem Ltd, IOL Chemicals and Pharmaceuticals Limited, Unichem Laboratories Ltd, Global Pharma Tek, Hetero Drugs Ltd, Manus Aktteva Biopharma LLP, Wellona Pharma, Atom pharma, Sinoway Industrial Co. Ltd, Cerata Pharmaceuticals LLP

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/losartan-potassium-active-pharmaceutical-ingredient-api-global-market-report

What Are The Key Regional Factors Influencing The Losartan Potassium Active Pharmaceutical Ingredient (API) Market Growth?

North America was the largest region in the losartan potassium API market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan potassium active pharmaceutical ingredient (API) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Losartan Potassium Active Pharmaceutical Ingredient (API) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24285&type=smp

Browse Through More Reports Similar to the Global Losartan Potassium Active Pharmaceutical Ingredient (API) Market 2025, By The Business Research Company

Dermatology Otc Medications Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dermatology-otc-medications-global-market-report

Dry Eye Medication Market 2025

https://www.thebusinessresearchcompany.com/report/dry-eye-medication-market

Dry Eye Medication Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dry-eye-medication-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info